Samsung Targets U.S. Drug Market With Remicade Knockoff
Samsung Group said its near-replica of Johnson & Johnson’s blockbuster arthritis drug Remicade has been accepted for review by the U.S. Food and Drug Administration.
Source: WSJ.com: Health - Category: Pharmaceuticals Tags: PAID Source Type: news
More News: Arthritis | Food and Drug Administration (FDA) | Health | Pharmaceuticals | Remicade | Rheumatology